IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Third Rock Ventures, LLC

Q2 2015 Holdings

Filed 2015-07-30 | 4 holdings | $960.8K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Sage Therapeutics Inc(SG7)COM78667J108$640.4K8,773,07366.7%
Blueprint Medicines Corp(2L9)COM09627Y109$195.8K7,393,05920.4%
Zafgen IncCOM98885E103$110.9K3,202,04511.5%
Eleven Biotherapeutics IncCOM286221106$13.7K4,841,5911.4%